MedPath

Stakeholder Assessment of Implementing the Commission on Cancer Operative Standards for Cancer Surgery

Completed
Conditions
Breast Carcinoma
Interventions
Other: Interview
Registration Number
NCT05583981
Lead Sponsor
Ohio State University Comprehensive Cancer Center
Brief Summary

This study investigates the barriers to implementing breast Synoptic Operative Reports. Information from this study may help researchers identify performance objectives for the breast Synoptic Operative Reports to be adopted, implemented and continued.

Detailed Description

PRIMARY OBJECTIVES:

I. To identify and describe barriers to implementing breast Synoptic Operative Reports (SOR) from multiple constructs.

Ia. Identify performance objectives - who must do what - for the breast SOR to be adopted, implemented, and continued.

OUTLINE:

Participants participate in interview over 30-60 minutes.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
31
Inclusion Criteria
  • Adults >= 18 years
  • Available phone or device for contact
  • English speaking
  • Works at Commission on Cancer (CoC) - accredited cancer program
Exclusion Criteria

none

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Observational (interview)InterviewParticipants participate in interview over 30-60 minutes.
Primary Outcome Measures
NameTimeMethod
Performance objectives for the breast Synoptic Operative Reports to be adopted, implemented, and continuedUp to 2 years

This is a qualitative study in which we will conduct in-depth, semi-structured interviews with key stakeholders.A template analysis identifying priori themes will be used, then coding for impact and/or implementation strategy.

Barriers to implementing breast Synoptic Operative ReportsUp to 2 years

This is a qualitative study in which we will conduct in-depth, semi-structured interviews with key stakeholders. A template analysis identifying priori themes will be used, then coding for impact and/or implementation strategy.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ohio State University Comprehensive Cancer Center

🇺🇸

Columbus, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath